These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18851840)

  • 1. Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells.
    Partovian C; Ju R; Zhuang ZW; Martin KA; Simons M
    Mol Cell; 2008 Oct; 32(1):140-9. PubMed ID: 18851840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways.
    Wang S; Amato KR; Song W; Youngblood V; Lee K; Boothby M; Brantley-Sieders DM; Chen J
    Mol Cell Biol; 2015 Apr; 35(7):1299-313. PubMed ID: 25582201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.
    Guertin DA; Stevens DM; Thoreen CC; Burds AA; Kalaany NY; Moffat J; Brown M; Fitzgerald KJ; Sabatini DM
    Dev Cell; 2006 Dec; 11(6):859-71. PubMed ID: 17141160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan 4 regulation of PDK1-dependent Akt activation.
    Ju R; Simons M
    Cell Signal; 2013 Jan; 25(1):101-5. PubMed ID: 22975683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2.
    Li W; Petrimpol M; Molle KD; Hall MN; Battegay EJ; Humar R
    Circ Res; 2007 Jan; 100(1):79-87. PubMed ID: 17110594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors.
    Lee D; Sykes SM; Kalaitzidis D; Lane AA; Kfoury Y; Raaijmakers MH; Wang YH; Armstrong SA; Scadden DT
    Stem Cell Reports; 2014 Nov; 3(5):832-40. PubMed ID: 25418727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IKK interacts with rictor and regulates mTORC2.
    Xu Y; Lai E; Liu J; Lin J; Yang C; Jia C; Li Y; Bai X; Li M
    Cell Signal; 2013 Nov; 25(11):2239-45. PubMed ID: 23872070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
    Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY
    Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the PI3K-Akt and mTORC1 signaling pathways promotes the elongation of vascular endothelial cells.
    Tsuji-Tamura K; Ogawa M
    J Cell Sci; 2016 Mar; 129(6):1165-78. PubMed ID: 26826185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of 14,15-EET on endothelial senescence through activation of mTOR complex 2/Akt signaling pathways.
    Yang C; Pan S; Yan S; Li Z; Yang J; Wang Y; Xiong Y
    Int J Biochem Cell Biol; 2014 May; 50():93-100. PubMed ID: 24607498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin regulates the phosphorylation of rictor.
    Akcakanat A; Singh G; Hung MC; Meric-Bernstam F
    Biochem Biophys Res Commun; 2007 Oct; 362(2):330-3. PubMed ID: 17707343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway.
    Elfenbein A; Rhodes JM; Meller J; Schwartz MA; Matsuda M; Simons M
    J Cell Biol; 2009 Jul; 186(1):75-83. PubMed ID: 19581409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis.
    Kim EK; Yun SJ; Ha JM; Kim YW; Jin IH; Yun J; Shin HK; Song SH; Kim JH; Lee JS; Kim CD; Bae SS
    Oncogene; 2011 Jun; 30(26):2954-63. PubMed ID: 21339740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis.
    Li J; Ren J; Liu X; Jiang L; He W; Yuan W; Yang J; Dai C
    Kidney Int; 2015 Sep; 88(3):515-27. PubMed ID: 25970154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
    Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
    Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of mTORC2 activation by the selective agonist of EPAC, 8-CPT-2Me-cAMP, in prostate cancer cells: assembly of a multiprotein signaling complex.
    Misra UK; Pizzo SV
    J Cell Biochem; 2012 May; 113(5):1488-500. PubMed ID: 22173835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17ß-Estradiol regulates mTORC2 sensitivity to rapamycin in adaptive cardiac remodeling.
    Kusch A; Schmidt M; Gürgen D; Postpieszala D; Catar R; Hegner B; Davidson MM; Mahmoodzadeh S; Dragun D
    PLoS One; 2015; 10(4):e0123385. PubMed ID: 25880554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex.
    Liu P; Gan W; Chin YR; Ogura K; Guo J; Zhang J; Wang B; Blenis J; Cantley LC; Toker A; Su B; Wei W
    Cancer Discov; 2015 Nov; 5(11):1194-209. PubMed ID: 26293922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of syndecan-4 side chains in turkey satellite cell apoptosis and focal adhesion formation.
    Song Y; McFarland DC; Velleman SG
    Cell Biol Int; 2012 May; 36(5):433-40. PubMed ID: 22272563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.